AU Patent

AU2019279761A1 — Compounds for pain treatment, compositions comprising same, and methods of using same

Assigned to Cersci Therapeutics Inc · Expires 2020-12-10 · 5y expired

What this patent protects

The invention relates to compounds of formula (I), compositions containing the same, and methods for treating and/or diminishing pain in a subject in need thereof. The compounds of formula (I) are effective for treating opioid-induced tachyphylaxis and opioid-induced hyperalgesia…

USPTO Abstract

The invention relates to compounds of formula (I), compositions containing the same, and methods for treating and/or diminishing pain in a subject in need thereof. The compounds of formula (I) are effective for treating opioid-induced tachyphylaxis and opioid-induced hyperalgesia.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019279761A1
Jurisdiction
AU
Classification
—
Expires
2020-12-10
Drug substance claim
No
Drug product claim
No
Assignee
Cersci Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.